Technologies
PDF


WARF: P04054US

  • Assigned to WARF as biological material.

A Supply of the Antibiotic Oligomycin


INVENTORS -

Glenn Chambliss

The Wisconsin Alumni Research Foundation is seeking commercial partners interested in a several hundred-gram quantity of the research chemical oligomycin.
OVERVIEWOligomycin is a highly stable macrolide antibiotic isolated from the fungus Streptomyces diastochromogenes. It is a potent inhibitor of mitochondrial ATPase and phosphoryl group transfer.
THE INVENTIONWARF has available for licensing a several hundred-gram quantity of the research chemical oligomycin. The available supply includes a mixture of oligomycins A, B and C, as well as purified preparations of oligomycin A and oligomycin B.
APPLICATIONS
  • Research that utilizes oligomycin
KEY BENEFITS
  • Provides a ready supply of a hard-to-isolate research chemical
Contact Information
For current licensing status, please contact Jennifer Gottwald at jennifer@warf.org or 608-960-9854.
The WARF Advantage

Since its founding in 1925 as the patenting and licensing organization for the University of Wisconsin-Madison, WARF has been working with business and industry to transform university research into products that benefit society. WARF intellectual property managers and licensing staff members are leaders in the field of university-based technology transfer. They are familiar with the intricacies of patenting, have worked with researchers in relevant disciplines, understand industries and markets, and have negotiated innovative licensing strategies to meet the individual needs of business clients.